Related Experiment Video
Updated: Nov 7, 2025

08:00
Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study
Published on: April 11, 2018
10.9K
Nasal Epithelial Cell-Based Models for Individualized Study in Cystic Fibrosis
Duncan E Keegan1,2, John J Brewington1,2
1Division of Pulmonary Medicine, Cincinnati Children's Hospital Medical Center (CCHMC), 3333 Burnet Avenue, Cincinnati, OH 45229, USA.
International Journal of Molecular Sciences
|April 30, 2021
Summary
New cystic fibrosis (CF) treatments are effective for many, but not all. Primary human nasal cell models offer a way to test personalized therapies for CF patients with rare variants or those unresponsive to current drugs.
Area of Science:
- Biomedical research
- Translational medicine
- Genetics
Background:
- Cystic Fibrosis (CF) care has advanced with CFTR modulator therapies.
- Some CF patients lack access to effective treatments due to rare CFTR variants or therapy non-responsiveness.
Purpose of the Study:
- To review the use of primary human nasal cells as a model for cystic fibrosis research.
- To highlight the potential of nasal cell models in predicting patient outcomes and informing personalized care.
Main Methods:
- Review of historical and current literature on ex vivo nasal cell culture for CF studies.
- Discussion of the application of nasal cell models for preclinical therapeutic testing and physiological assessment.
Main Results:
- Nasal cells provide a valuable ex vivo model for studying individual CF patient physiology.
- Evolving nasal cell culture techniques are enabling better prediction of patient responses to therapies.
Conclusions:
- Primary human nasal cell models are crucial for addressing unmet needs in CF care.
- These models facilitate personalized medicine by enabling individual therapeutic assessment and outcome prediction for cystic fibrosis patients.
Related Concept Videos
Cystic Fibrosis: Pathogenesis
522
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
522
Cystic Fibrosis: Management
302
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
302

